EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Kinetically Inert Platinum (II) Complexes for Improving Anticancer Therapy: Recent Developments and Road Ahead

Tushar Ranjan Panda iD, Malay Patra iD

ChemMedChem · 2024

DOI: 10.1002/cmdc.202400196 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ChemMedChem, 2024. Verfasst von Tushar Ranjan Panda und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medicinal Chemistry and Cell Biology, Department of Chemical Sciences, Tata Institute of Fundamental Research, Homi Bhabha Road, Navy N…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms, Organoplatinum Compounds. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 110 Literaturangaben. Gefördert von: Department of Atomic Energy, Tata Institute of Fundamental Research, Department of Atomic Energy, Government of India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The search for better chemotherapeutic drugs to alleviate the deficiencies of existing platinum (Pt) drugs has picked up the pace in the millennium. There has been a disparate effort to design better and safer Pt drugs to deal with the problems of deactivation, Pt resistance and toxic side effects of clinical Pt drugs. In this review, we have discussed the potential of kinetically inert Pt complexes as an emerging class of next‐generation Pt drugs. The introduction gives an overview about the development, use, mechanism of action and side effects of clinical Pt drugs as well as the various approaches to improve some of their pharmacological properties. We then describe the impact of kinetic lability on the pharmacology of functional Pt drugs including deactivation, antitumor efficacy, toxicity and resistance. Following a brief overview of numerous pharmacological advantages that a non‐functional kinetically inert Pt complex can offer; we discussed structurally different classes of kinetically inert Pt (II) complexes highlighting their unique pharmacological features.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsNeoplasmsOrganoplatinum CompoundsHumansCoordination ComplexesKineticsMolecular StructurePlatinum

Stichwörter der Autor:innen

AntitumorKinetic inertnessNephrotoxicityPlatinum drugsPlatinum resistance

Substanzen

Antineoplastic AgentsOrganoplatinum CompoundsCoordination ComplexesPlatinum

Autor:innen und Institutionen

  • Laboratory of Medicinal Chemistry and Cell Biology, Department of Chemical Sciences, Tata Institute of Fundamental Research, Homi Bhabha Road, Navy Nagar, 400005, Mumbai, India.

ORCID-Profile: Tushar Ranjan Panda, Malay Patra

Förderung

  • Department of Atomic Energy
  • Tata Institute of Fundamental Research
  • Department of Atomic Energy, Government of India

Zitieren

APA

Panda, T. R., & Patra, M. (2024). Kinetically Inert Platinum (II) Complexes for Improving Anticancer Therapy: Recent Developments and Road Ahead. ChemMedChem. https://doi.org/10.1002/cmdc.202400196

Vancouver

Panda TR, Patra M. Kinetically Inert Platinum (II) Complexes for Improving Anticancer Therapy: Recent Developments and Road Ahead. ChemMedChem. 2024. doi:10.1002/cmdc.202400196

BibTeX
@article{Panda2024,
  author = {Panda, Tushar Ranjan and Patra, Malay},
  title = {Kinetically Inert Platinum (II) Complexes for Improving Anticancer Therapy: Recent Developments and Road Ahead},
  journal = {ChemMedChem},
  year = {2024},
  doi = {10.1002/cmdc.202400196}
}
Kostenlos starten →